St Jude Medical Inc (STJ)

STJ (NYSE:Health Services)
$60.38
pos +0.25
+0.42%
Today's Range: 59.78 - 60.47 | STJ Avg Daily Volume: 1,541,300
Last Update: 10/01/14 - 4:00 PM EDT
Volume: 2,735,305
YTD Performance: -1.31%
Open: $60.36
Previous Close: $60.13
52 Week Range: $51.79 - $71.90
Oustanding Shares: 284,693,423
Market Cap: 17,406,155,882
6-Month Chart
TheStreet Ratings Grade for STJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 14 12
Moderate Buy 1 1 1 1
Hold 8 7 7 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.85 1.80 1.80 1.83
Latest Dividend: 0.27
Latest Dividend Yield: 1.68%
Dividend Ex-Date: 09/26/14
Price Earnings Ratio: 14.68
Price Earnings Comparisons:
STJ Sector Avg. S&P 500
14.68 19.70 28.41
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.08% 14.77% 65.65%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.07 0.02
Net Income -8.00 -0.24 -0.09
EPS 4.20 -0.09 -0.03
Earnings for STJ:
EBITDA 1.65B
Revenue 5.50B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.96 $1.05 $3.99 $4.33
Number of Analysts 13 12 16 16
High Estimate $0.97 $1.08 $4.02 $4.42
Low Estimate $0.94 $1.02 $3.94 $4.20
Prior Year $0.90 $0.99 $3.76 $3.99
Growth Rate (Year over Year) 6.24% 6.48% 6.15% 8.38%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

updateSt. Jude rated new Neutral at Sterne Agee

Jul 29, 2014 | 7:55 AM EDT

Coverage of STJ was started with a Neutral rating, Sterne Agee said. $74 price target. Uncertainty remains around the rollout of new products. 

By

Doug Kass

 | Jul 14, 2014 | 8:06 AM EDT
Where it began.
By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Gary Morrow

 | May 28, 2014 | 5:15 PM EDT

I doubt its rally stalls here

bullishSt. Jude upgraded at William Blair

Feb 10, 2014 | 7:51 AM EST

STJ was upgraded to Outperform, William Blair said. New product portfolio should drive growth in the coming quarters. 

bullishSt. Jude upgraded at Stifel

Feb 10, 2014 | 7:18 AM EST

STJ was upgraded from Hold to Buy, Stifel Nicolaus said. $75 price target. Company can show accelerating sales growth and expanding margins. 

 

updateSTJ Investor Mtg.

Feb 7, 2014 | 7:19 AM EST

STJ - St. Jude Medical, Inc. 2014 Investor Meeting - 8AM 

bullishSt. Jude upgraded at Morgan Stanley

Jan 6, 2014 | 8:22 AM EST

STJ was upgraded from Equal-weight to Overweight, Morgan Stanley said. $75 price target. Organic growth is accelerating. 

updateSt. Jude Medical upgraded at BMO

Dec 16, 2013 | 8:08 AM EST

STJ was upgraded to Outperform from Marketperform, BMO said. Benefits from improving ICD market, FDA approval of CardioMEMS, and new product launches. $66 price target.

By

Scott Redler

 | Oct 1, 2013 | 6:54 PM EDT

Maintain a stock-specific approach until a clearer trend develops.

HLF closed Wednesday trading at $43.63, down small with IV30™ down 3.2%. Conclusion ...
The Russell 2000 has led the broader market lower and today it returned to its 2014 lows, ...
Here are the next potential support decisions to watch in SPX cash. Note that the current...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.